Victoria Chapman, BSc, PhD - Publications

Affiliations: 
Biomedical Sciences University of Nottingham, Nottingham, England, United Kingdom 
Area:
Cannabinoids, pain

129 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gowler PRW, Mapp PI, Burston JJ, Shahtaheri M, Walsh DA, Chapman V. Refining surgical models of osteoarthritis in mice and rats alters pain phenotype but not joint pathology. Plos One. 15: e0239663. PMID 32991618 DOI: 10.1371/journal.pone.0239663  0.4
2020 Aso K, Shahtaheri SM, Hill R, Wilson D, McWilliams DF, Nwosu LN, Chapman V, Walsh DA. Contribution of nerves within osteochondral channels to osteoarthritis knee pain in humans and rats. Osteoarthritis and Cartilage. PMID 32470596 DOI: 10.1016/j.joca.2020.05.010  0.36
2020 Millar B, McWilliams DF, Abhishek A, Akin-Akinyosoye K, Auer DP, Chapman V, Doherty M, Ferguson E, Gladman JRF, Greenhaff P, Stocks J, Valdes AM, Walsh DA. Investigating musculoskeletal health and wellbeing; a cohort study protocol. Bmc Musculoskeletal Disorders. 21: 182. PMID 32199451 DOI: 10.1186/s12891-020-03195-4  0.36
2019 Gowler PRW, Li L, Woodhams SG, Bennett AJ, Suzuki R, Walsh DA, Chapman V. Peripheral brain derived neurotrophic factor contributes to chronic osteoarthritis joint pain. Pain. PMID 31479064 DOI: 10.1097/j.pain.0000000000001694  0.48
2019 Woodhams SG, Markus R, Gowler PRW, Self TJ, Chapman V. Cell type-specific super-resolution imaging reveals an increase in calcium-permeable AMPA receptors at spinal peptidergic terminals as an anatomical correlate of inflammatory pain. Pain. PMID 31425488 DOI: 10.1097/j.pain.0000000000001672  0.48
2019 Ashraf S, Radhi M, Gowler P, Burston JJ, Gandhi RD, Thorn GJ, Piccinini AM, Walsh DA, Chapman V, de Moor CH. The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis. Scientific Reports. 9: 4696. PMID 30886197 DOI: 10.1038/s41598-019-41140-1  0.4
2019 Burston JJ, Valdes AM, Woodhams SG, Mapp PI, Stocks J, Watson DJG, Gowler PRW, Xu L, Sagar DR, Fernandes G, Frowd N, Marshall L, Zhang W, Doherty M, Walsh DA, ... Chapman V, et al. The impact of anxiety on chronic musculoskeletal pain and the role of astrocyte activation. Pain. 160: 658-669. PMID 30779717 DOI: 10.1097/j.pain.0000000000001445  0.84
2018 Nwosu LN, Gowler PRW, Burston JJ, Rizoska B, Tunblad K, Lindström E, Grabowska U, Li L, McWilliams DF, Walsh DA, Chapman V. Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain. Pain Reports. 3: e685. PMID 30706033 DOI: 10.1097/PR9.0000000000000685  0.4
2018 Alharthi N, Christensen P, Hourani W, Ortori C, Barrett DA, Bennett AJ, Chapman V, Alexander SPH. n-3 polyunsaturated N-acylethanolamines are CB cannabinoid receptor-preferring endocannabinoids. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 1863: 1433-1440. PMID 30591150 DOI: 10.1016/j.bbalip.2018.08.003  0.92
2018 Greenspon CM, Battell EE, Devonshire IM, Donaldson LF, Chapman V, Hathway GJ. Lamina-specific population encoding of cutaneous signals in the spinal dorsal horn using multi-electrode arrays. The Journal of Physiology. PMID 30390415 DOI: 10.1113/JP277036  0.36
2018 Valdes AM, Ravipati S, Pousinis P, Menni C, Mangino M, Abhishek A, Chapman V, Barrett DA, Doherty M. Omega-6 oxylipins generated by soluble epoxide hydrolase are associated with knee osteoarthritis. Journal of Lipid Research. PMID 29986999 DOI: 10.1194/jlr.P085118  0.6
2018 Haywood AR, Hathway GJ, Chapman V. Differential contributions of peripheral and central mechanisms to pain in a rodent model of osteoarthritis. Scientific Reports. 8: 7122. PMID 29740093 DOI: 10.1038/s41598-018-25581-8  0.36
2018 de Visser HM, Mastbergen SC, Ravipati S, Welsing PMJ, Pinto FC, Lafeber FPJG, Chapman V, Barrett DA, Weinans H. Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation. Plos One. 13: e0196308. PMID 29684084 DOI: 10.1371/journal.pone.0196308  0.6
2017 Okine BN, Spicer C, Millns P, Bennett A, Chapman V. Systemic administration of WY-14643, a selective synthetic agonist of peroxisome proliferator activator receptor-alpha, alters spinal neuronal firing in a rodent model of neuropathic pain. Scandinavian Journal of Pain. 9: 42-48. PMID 29911649 DOI: 10.1016/j.sjpain.2015.06.004  0.6
2017 Chapman V, Markides H, Sagar DR, Xu L, Burston JJ, Mapp P, Kay A, Morris RH, Kehoe O, El Haj AJ. Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis. Stem Cells International. 2017: 2905104. PMID 29434641 DOI: 10.1155/2017/2905104  0.84
2017 Valdes AM, Ravipati S, Menni C, Abhishek A, Metrustry S, Harris J, Nessa A, Williams FMK, Spector TD, Doherty M, Chapman V, Barrett DA. Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humans. Scientific Reports. 7: 10748. PMID 28883634 DOI: 10.1038/s41598-017-09516-3  0.6
2017 H-T Kwok C, Devonshire IM, Imraish A, Greenspon CM, Lockwood S, Fielden C, Cooper A, Woodhams S, Sarmad S, Ortori CA, Barrett DA, Kendall D, Bennett AJ, Chapman V, Hathway GJ. Age dependent plasticity in endocannabinoid modulation of pain processing through postnatal development. Pain. PMID 28767505 DOI: 10.1097/j.pain.0000000000001027  0.92
2017 Devonshire IM, Burston JJ, Xu L, Lillywhite A, Prior MJ, Watson DJG, Greenspon CM, Iwabuchi SJ, Auer DP, Chapman V. Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: a new window to study experimental spontaneous pain? Neuroimage. PMID 28633971 DOI: 10.1016/j.neuroimage.2017.06.034  0.4
2017 Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer V. The cannabinoid system and pain. Neuropharmacology. PMID 28625720 DOI: 10.1016/j.neuropharm.2017.06.015  0.72
2017 Nwosu LN, Allen M, Wyatt L, Huebner JL, Chapman V, Walsh DA, Kraus VB. Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA. Osteoarthritis and Cartilage. PMID 28087412 DOI: 10.1016/j.joca.2017.01.002  0.36
2016 Huang J, Burston JJ, Li L, Ashraf S, Mapp PI, Bennett AJ, Ravipati S, Pousinis P, Barrett DA, Scammell BE, Chapman V. Targeting the D-series resolvin receptor system for the treatment of osteoarthritic pain. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27860453 DOI: 10.1002/art.40001  0.6
2016 Meesawatsom P, Burston J, Hathway G, Bennett A, Chapman V. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. Journal of Neuroinflammation. 13: 233. PMID 27589850 DOI: 10.1186/s12974-016-0676-6  0.92
2016 Burston JJ, Mapp PI, Sarmad S, Barrett DA, Niphakis MJ, Cravatt BF, Walsh DA, Chapman V. Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain. British Journal of Pharmacology. PMID 27501482 DOI: 10.1111/bph.13574  0.6
2016 Alsalem M, Millns P, Altarifi A, El-Salem K, Chapman V, Kendall DA. Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat. Bmc Pharmacology & Toxicology. 17: 31. PMID 27439609 DOI: 10.1186/s40360-016-0074-9  0.92
2016 Nwosu LN, Mapp PI, Chapman V, Walsh DA. Relationship between structural pathology and pain behaviour in a model of osteoarthritis (OA). Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. PMID 27349460 DOI: 10.1016/j.joca.2016.06.012  0.36
2016 Xu L, Nwosu LN, Burston JJ, Millns PJ, Sagar DR, Mapp PI, Meesawatsom P, Li L, Bennett AJ, Walsh DA, Chapman V. The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. PMID 27208420 DOI: 10.1016/j.joca.2016.05.015  0.92
2016 Nieto FR, Clark AK, Grist J, Hathway GJ, Chapman V, Malcangio M. Neuron-immune mechanisms contribute to pain in early stages of arthritis. Journal of Neuroinflammation. 13: 96. PMID 27130316 DOI: 10.1186/s12974-016-0556-0  0.36
2016 Abaei M, Sagar DR, Stockley EG, Spicer CH, Prior M, Chapman V, Auer DP. Neural correlates of hyperalgesia in the monosodium iodoacetate model of osteoarthritis pain. Molecular Pain. 12. PMID 27068285 DOI: 10.1177/1744806916642445  0.84
2015 Nwosu LN, Mapp PI, Chapman V, Walsh DA. Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis. Annals of the Rheumatic Diseases. PMID 26286016 DOI: 10.1136/annrheumdis-2014-207203  0.92
2015 Woodhams SG, Sagar DR, Burston JJ, Chapman V. The role of the endocannabinoid system in pain. Handbook of Experimental Pharmacology. 227: 119-43. PMID 25846617 DOI: 10.1007/978-3-662-46450-2_7  0.92
2015 Byrne FM, Cheetham S, Vickers S, Chapman V. Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments. Journal of Diabetes Research. 2015: 752481. PMID 25759824 DOI: 10.1155/2015/752481  0.92
2015 Nieto FR, Clark AK, Grist J, Chapman V, Malcangio M. Calcitonin gene-related Peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain States in collagen-induced arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1668-77. PMID 25707377 DOI: 10.1002/art.39082  0.92
2015 Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. Acta Physiologica (Oxford, England). 214: 63-74. PMID 25704169 DOI: 10.1111/apha.12474  0.92
2015 Sagar DR, Nwosu L, Walsh DA, Chapman V. Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 23: 906-13. PMID 25623624 DOI: 10.1016/j.joca.2015.01.010  0.92
2015 Kelly S, Chapman RJ, Woodhams S, Sagar DR, Turner J, Burston JJ, Bullock C, Paton K, Huang J, Wong A, McWilliams DF, Okine BN, Barrett DA, Hathway GJ, Walsh DA, ... Chapman V, et al. Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain. Annals of the Rheumatic Diseases. 74: 252-9. PMID 24152419 DOI: 10.1136/annrheumdis-2013-203413  0.84
2015 Okine BN, Spicer C, Millns P, Bennett A, Chapman V. Systemic administration of WY-14643, a selective synthetic agonist of peroxisome proliferator activator receptor-alpha, alters spinal neuronal firing in a rodent model of neuropathic pain Scandinavian Journal of Pain. 9: 42-48. DOI: 10.1016/j.sjpain.2015.06.004  0.92
2014 Wong A, Sagar DR, Ortori CA, Kendall DA, Chapman V, Barrett DA. Simultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis. Journal of Lipid Research. 55: 1902-13. PMID 25062663 DOI: 10.1194/jlr.M048694  0.92
2014 Suokas AK, Sagar DR, Mapp PI, Chapman V, Walsh DA. Design, study quality and evidence of analgesic efficacy in studies of drugs in models of OA pain: a systematic review and a meta-analysis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 22: 1207-23. PMID 25008207 DOI: 10.1016/j.joca.2014.06.015  0.92
2014 Ashraf S, Mapp PI, Burston J, Bennett AJ, Chapman V, Walsh DA. Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis. Annals of the Rheumatic Diseases. 73: 1710-8. PMID 23852764 DOI: 10.1136/annrheumdis-2013-203416  0.92
2014 Sagar DR, Ashraf S, Xu L, Burston JJ, Menhinick MR, Poulter CL, Bennett AJ, Walsh DA, Chapman V. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Annals of the Rheumatic Diseases. 73: 1558-65. PMID 23723320 DOI: 10.1136/annrheumdis-2013-203260  0.92
2013 Burston JJ, Sagar DR, Shao P, Bai M, King E, Brailsford L, Turner JM, Hathway GJ, Bennett AJ, Walsh DA, Kendall DA, Lichtman A, Chapman V. Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint. Plos One. 8: e80440. PMID 24282543 DOI: 10.1371/journal.pone.0080440  0.92
2013 Mapp PI, Sagar DR, Ashraf S, Burston JJ, Suri S, Chapman V, Walsh DA. Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 21: 1336-45. PMID 23973148 DOI: 10.1016/j.joca.2013.06.031  0.92
2013 Niphakis MJ, Cognetta AB, Chang JW, Buczynski MW, Parsons LH, Byrne F, Burston JJ, Chapman V, Cravatt BF. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. Acs Chemical Neuroscience. 4: 1322-32. PMID 23731016 DOI: 10.1021/cn400116z  0.92
2013 Alsalem M, Wong A, Millns P, Arya PH, Chan MS, Bennett A, Barrett DA, Chapman V, Kendall DA. The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms. British Journal of Pharmacology. 168: 1961-74. PMID 23278358 DOI: 10.1111/bph.12092  0.92
2012 Rani Sagar D, Burston JJ, Woodhams SG, Chapman V. Dynamic changes to the endocannabinoid system in models of chronic pain. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3300-11. PMID 23108548 DOI: 10.1098/rstb.2011.0390  0.92
2012 Woodhams SG, Wong A, Barrett DA, Bennett AJ, Chapman V, Alexander SP. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. British Journal of Pharmacology. 167: 1609-19. PMID 22924700 DOI: 10.1111/j.1476-5381.2012.02179.x  0.92
2012 Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. British Journal of Pharmacology. 167: 627-40. PMID 22595021 DOI: 10.1111/j.1476-5381.2012.02028.x  0.92
2012 Vincent TL, Williams RO, Maciewicz R, Silman A, Garside P, Bevan S, Chanalaris A, Chapman V, Cope A, Cruwys S, Dell'Accio F, Gaskin P, Gilroy D, Glasson S, Hegen M, et al. Mapping pathogenesis of arthritis through small animal models Rheumatology (United Kingdom). 51: 1931-1941. PMID 22427408 DOI: 10.1093/rheumatology/kes035  0.92
2012 Butler RK, Ford GK, Hogan M, Roche M, Doyle KM, Kelly JP, Kendall DA, Chapman V, Finn DP. Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase. Journal of Psychopharmacology (Oxford, England). 26: 83-91. PMID 21926424 DOI: 10.1177/0269881111413823  0.92
2011 Sagar DR, Burston JJ, Hathway GJ, Woodhams SG, Pearson RG, Bennett AJ, Kendall DA, Scammell BE, Chapman V. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Molecular Pain. 7: 88. PMID 22093915 DOI: 10.1186/1744-8069-7-88  0.92
2011 Walsh DA, Chapman V. Bisphosphonates for osteoarthritis. Arthritis Research & Therapy. 13: 128. PMID 21996085 DOI: 10.1186/ar3448  0.92
2011 Valdes AM, De Wilde G, Doherty SA, Lories RJ, Vaughn FL, Laslett LL, Maciewicz RA, Soni A, Hart DJ, Zhang W, Muir KR, Dennison EM, Wheeler M, Leaverton P, Cooper C, ... ... Chapman V, et al. The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Annals of the Rheumatic Diseases. 70: 1556-61. PMID 21616913 DOI: 10.1136/ard.2010.148122  0.92
2011 Lichtman AH, Chapman V. A FAAH-fetched approach to treat osteoarthritis pain. Pain. 152: 959-60. PMID 21371823 DOI: 10.1016/j.pain.2011.02.034  0.92
2010 Sagar DR, Staniaszek LE, Okine BN, Woodhams S, Norris LM, Pearson RG, Garle MJ, Alexander SP, Bennett AJ, Barrett DA, Kendall DA, Scammell BE, Chapman V. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis and Rheumatism. 62: 3666-76. PMID 20722027 DOI: 10.1002/art.27698  0.92
2010 Staniaszek LE, Norris LM, Kendall DA, Barrett DA, Chapman V. Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids. British Journal of Pharmacology. 160: 669-76. PMID 20590570 DOI: 10.1111/j.1476-5381.2010.00703.x  0.92
2010 Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. The European Journal of Neuroscience. 31: 1414-22. PMID 20384778 DOI: 10.1111/j.1460-9568.2010.07162.x  0.92
2009 Sagar DR, Jhaveri M, Chapman V. Targeting the cannabinoid system to produce analgesia. Current Topics in Behavioral Neurosciences. 1: 275-87. PMID 21104388 DOI: 10.1007/978-3-540-88955-7_11  0.92
2009 Sagar DR, Gaw AG, Okine BN, Woodhams SG, Wong A, Kendall DA, Chapman V. Dynamic regulation of the endocannabinoid system: implications for analgesia. Molecular Pain. 5: 59. PMID 19814807 DOI: 10.1186/1744-8069-5-59  0.92
2009 Jean-Gilles L, Feng S, Tench CR, Chapman V, Kendall DA, Barrett DA, Constantinescu CS. Plasma endocannabinoid levels in multiple sclerosis. Journal of the Neurological Sciences. 287: 212-5. PMID 19695579 DOI: 10.1016/j.jns.2009.07.021  0.92
2009 Guasti L, Richardson D, Jhaveri M, Eldeeb K, Barrett D, Elphick MR, Alexander SP, Kendall D, Michael GJ, Chapman V. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Molecular Pain. 5: 35. PMID 19570201 DOI: 10.1186/1744-8069-5-35  0.92
2009 Jones KL, Finn DP, Governo RJ, Prior MJ, Morris PG, Kendall DA, Marsden CA, Chapman V. Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain. Neuropharmacology. 56: 405-13. PMID 18930746 DOI: 10.1016/j.neuropharm.2008.09.010  0.92
2009 Chapman V, Kendall D, Sagar DR. Cannabinoid receptor mediated analgesia: Novel targets for chronic pain states Synaptic Plasticity in Pain. 337-351. DOI: 10.1007/978-1-4419-0226-9_15  0.92
2008 Sagar DR, Kendall DA, Chapman V. Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain. British Journal of Pharmacology. 155: 1297-306. PMID 18724387 DOI: 10.1038/bjp.2008.335  0.92
2008 Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology. 55: 85-93. PMID 18534634 DOI: 10.1016/j.neuropharm.2008.04.018  0.92
2008 Brignell JL, Chapman V, Kendall DA. Comparison of icilin- and cold-evoked responses of spinal neurones, and their modulation of mechanical activity, in a model of neuropathic pain. Brain Research. 1215: 87-96. PMID 18479674 DOI: 10.1016/j.brainres.2008.03.072  0.92
2008 Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ, Chapman V. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Research & Therapy. 10: R43. PMID 18416822 DOI: 10.1186/ar2401  0.92
2008 Jhaveri MD, Elmes SJ, Richardson D, Barrett DA, Kendall DA, Mason R, Chapman V. Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. The European Journal of Neuroscience. 27: 1722-30. PMID 18380669 DOI: 10.1111/j.1460-9568.2008.06162.x  0.92
2008 Governo RJ, Morris PG, Marsden CA, Chapman V. Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study. British Journal of Pharmacology. 153: 1558-67. PMID 18264121 DOI: 10.1038/bjp.2008.27  0.92
2008 Jhaveri MD, Elmes SJR, Richardson D, Barrett DA, Kendall DA, Mason R, Chapman V. Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats (European Journal of Neuroscience (2008) 27, (1722-1730)) European Journal of Neuroscience. 27: 2482. DOI: 10.1111/j.1460-9568.2008.06274.x  0.92
2007 Jhaveri MD, Sagar DR, Elmes SJ, Kendall DA, Chapman V. Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Molecular Neurobiology. 36: 26-35. PMID 17952647 DOI: 10.1007/s12035-007-8007-7  0.92
2007 Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. British Journal of Pharmacology. 152: 624-32. PMID 17704819 DOI: 10.1038/sj.bjp.0707433  0.92
2007 Finn DP, Fone KC, Beckett SR, Baxter JA, Ansell L, Marsden CA, Chapman V. The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. European Journal of Pharmacology. 569: 59-63. PMID 17599826 DOI: 10.1016/j.ejphar.2007.05.020  0.92
2007 Governo RJ, Prior MJ, Morris PG, Marsden CA, Chapman V. Validation of an automated punctate mechanical stimuli delivery system designed for fMRI studies in rodents. Journal of Neuroscience Methods. 163: 31-7. PMID 17368787 DOI: 10.1016/j.jneumeth.2007.02.006  0.92
2007 Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Analytical Biochemistry. 360: 216-26. PMID 17141174 DOI: 10.1016/j.ab.2006.10.039  0.92
2007 Moylan Governo RJ, Morris PG, William Prior MJ, Marsden CA, Chapman V. Corrigendum to "Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: A functional magnetic resonance imaging study" [Pain 126 (2006) 35-45] (DOI:10.1016/j.pain.2006.06.012) Pain. 129: 230. DOI: 10.1016/j.pain.2007.03.010  0.92
2006 Millns PJ, Chimenti M, Ali N, Ryland E, de Lago E, Fernandez-Ruiz J, Chapman V, Kendall DA. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. The European Journal of Neuroscience. 24: 3489-95. PMID 17229097 DOI: 10.1111/j.1460-9568.2006.05236.x  0.92
2006 Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13318-27. PMID 17182782 DOI: 10.1523/JNEUROSCI.3326-06.2006  0.92
2006 Moylan Governo RJ, Morris PG, Prior MJ, Marsden CA, Chapman V. Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: a functional magnetic resonance imaging study. Pain. 126: 35-45. PMID 16843597 DOI: 10.1016/j.pain.2006.06.012  0.92
2006 Finn DP, Jhaveri MD, Beckett SR, Madjd A, Kendall DA, Marsden CA, Chapman V. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats. Neuroscience. 138: 1309-17. PMID 16426764 DOI: 10.1016/j.neuroscience.2005.11.063  0.92
2005 Elmes SJ, Winyard LA, Medhurst SJ, Clayton NM, Wilson AW, Kendall DA, Chapman V. Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Pain. 118: 327-35. PMID 16289798 DOI: 10.1016/j.pain.2005.09.005  0.92
2005 Sagar DR, Kelly S, Millns PJ, O'Shaughnessey CT, Kendall DA, Chapman V. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. The European Journal of Neuroscience. 22: 371-9. PMID 16045490 DOI: 10.1111/j.1460-9568.2005.04206.x  0.92
2005 Jhaveri MD, Elmes SJ, Kendall DA, Chapman V. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats. The European Journal of Neuroscience. 22: 361-70. PMID 16045489 DOI: 10.1111/j.1460-9568.2005.04227.x  0.92
2005 Shah YB, Haynes L, Prior MJ, Marsden CA, Morris PG, Chapman V. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology. 180: 761-73. PMID 15778889 DOI: 10.1007/s00213-005-2214-6  0.92
2005 Abdul Aziz AA, Finn DP, Mason R, Chapman V. Comparison of responses of ventral posterolateral and posterior complex thalamic neurons in naive rats and rats with hindpaw inflammation: mu-opioid receptor mediated inhibitions. Neuropharmacology. 48: 607-16. PMID 15755488 DOI: 10.1016/j.neuropharm.2004.11.002  0.92
2004 Elmes SJ, Jhaveri MD, Smart D, Kendall DA, Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. The European Journal of Neuroscience. 20: 2311-20. PMID 15525273 DOI: 10.1111/j.1460-9568.2004.03690.x  0.92
2004 Elmes SJ, Millns PJ, Smart D, Kendall DA, Chapman V. Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons. Brain Research. 1022: 205-13. PMID 15353230 DOI: 10.1016/j.brainres.2004.07.005  0.92
2004 Finn DP, Beckett SR, Richardson D, Kendall DA, Marsden CA, Chapman V. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. The European Journal of Neuroscience. 20: 848-52. PMID 15255996 DOI: 10.1111/j.1460-9568.2004.03509.x  0.92
2004 Sagar DR, Smith PA, Millns PJ, Smart D, Kendall DA, Chapman V. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat. The European Journal of Neuroscience. 20: 175-84. PMID 15245490 DOI: 10.1111/j.1460-9568.2004.03481.x  0.92
2004 Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, Chapman V. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. The European Journal of Neuroscience. 19: 678-86. PMID 14984418 DOI: 10.1111/j.0953-816X.2004.03177.x  0.92
2004 Finn DP, Jhaveri MD, Beckett SR, Kendall DA, Marsden CA, Chapman V. Cannabinoids modulate ultrasound-induced aversive responses in rats. Psychopharmacology. 172: 41-51. PMID 14634713 DOI: 10.1007/s00213-003-1629-1  0.92
2004 Finn DP, Chapman V. Cannabinoids as analgesic agents: Evidence from in vivo studies Current Neuropharmacology. 2: 75-89. DOI: 10.2174/1570159043476918  0.92
2003 Kelly S, Jhaveri MD, Sagar DR, Kendall DA, Chapman V. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. The European Journal of Neuroscience. 18: 2239-43. PMID 14622184 DOI: 10.1046/j.1460-9568.2003.02957.x  0.92
2003 Sokal DM, Chapman V. Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in inflamed and neuropathic rats in vivo. Brain Research. 987: 67-75. PMID 14499947 DOI: 10.1016/S0006-8993(03)03255-4  0.92
2003 Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA, Chapman V. Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology. 45: 594-604. PMID 12941373 DOI: 10.1016/S0028-3908(03)00235-1  0.92
2003 Kelly S, Chapman V. Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation. European Journal of Pharmacology. 474: 209-16. PMID 12921864 DOI: 10.1016/S0014-2999(03)02085-5  0.92
2003 Sokal DM, Elmes SJ, Kendall DA, Chapman V. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology. 45: 404-11. PMID 12871657 DOI: 10.1016/S0028-3908(03)00195-3  0.92
2003 Finn DP, Chapman V, Jhaveri MD, Samanta S, Manders T, Bowden J, Matthews L, Marsden CA, Beckett SR. The role of the central nucleus of the amygdala in nociception and aversion. Neuroreport. 14: 981-4. PMID 12802187 DOI: 10.1097/01.wnr.0000069062.85441.29  0.92
2003 Sokal DM, Chapman V. Effects of spinal administration of muscimol on C- and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats. Brain Research. 962: 213-20. PMID 12543472 DOI: 10.1016/S0006-8993(02)04057-X  0.92
2002 Kelly S, Chapman V. Effects of peripheral nerve injury on functional spinal VR1 receptors. Neuroreport. 13: 1147-50. PMID 12151758  0.92
2002 Kelly S, Chapman V. Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats. Brain Research. 935: 103-8. PMID 12062478 DOI: 10.1016/S0006-8993(02)02552-0  0.92
2002 Iversen L, Chapman V. Cannabinoids: a real prospect for pain relief? Current Opinion in Pharmacology. 2: 50-5. PMID 11786308 DOI: 10.1016/S1471-4892(01)00120-5  0.92
2001 Kelly S, Chapman V. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. Journal of Neurophysiology. 86: 3061-4. PMID 11731561  0.92
2001 Sokal DM, Chapman V. Spinal GABA(B)-receptor antagonism increases nociceptive transmission in vivo. Neuroreport. 12: 3247-50. PMID 11711865  0.92
2001 Chapman V. Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats. Neuropharmacology. 41: 870-7. PMID 11684151 DOI: 10.1016/S0028-3908(01)00125-3  0.92
2001 Millns PJ, Chapman V, Kendall DA. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. British Journal of Pharmacology. 132: 969-71. PMID 11226126 DOI: 10.1038/sj.bjp.0703919  0.92
2000 Harris J, Drew LJ, Chapman V. Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. Neuroreport. 11: 2817-9. PMID 10976969  0.92
2000 Drew LJ, Harris J, Millns PJ, Kendall DA, Chapman V. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. The European Journal of Neuroscience. 12: 2079-86. PMID 10886347 DOI: 10.1046/j.1460-9568.2000.00101.x  0.92
2000 Carpenter KJ, Chapman V, Dickenson AH. Neuronal inhibitory effects of methadone are predominantly opioid receptor mediated in the rat spinal cord in vivo. European Journal of Pain (London, England). 4: 19-26. PMID 10833552 DOI: 10.1053/eujp.1999.0147  0.92
2000 Bester H, Chapman V, Besson JM, Bernard JF. Physiological properties of the lamina I spinoparabrachial neurons in the rat. Journal of Neurophysiology. 83: 2239-59. PMID 10758132  0.92
1999 Chapman V. The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. British Journal of Pharmacology. 127: 1765-7. PMID 10482905 DOI: 10.1038/sj.bjp.0702758  0.92
1999 Suzuki R, Chapman V, Dickenson AH. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain. 80: 215-28. PMID 10204734 DOI: 10.1016/S0304-3959(98)00208-5  0.92
1998 Chapman V, Ng J, Dickenson AH. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats. Pain. 77: 289-96. PMID 9808354 DOI: 10.1016/S0304-3959(98)00106-7  0.92
1998 Honoré P, Buritova J, Chapman V, Besson JM. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain. 75: 281-93. PMID 9583764 DOI: 10.1016/S0304-3959(98)00006-2  0.92
1998 Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain. 75: 261-72. PMID 9583762 DOI: 10.1016/S0304-3959(98)00004-9  0.92
1998 Chapman V, Suzuki R, Dickenson AH. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. The Journal of Physiology. 507: 881-94. PMID 9508847 DOI: 10.1111/j.1469-7793.1998.881bs.x  0.92
1997 Chapman V, Diaz A, Dickenson AH. Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. British Journal of Pharmacology. 122: 1537-9. PMID 9422796 DOI: 10.1038/sj.bjp.0701594  0.92
1997 Chapman V, Wildman MA, Dickenson AH. Distinct electrophysiological effects of two spinally administered membrane stabilising drugs, bupivacaine and lamotrigine. Pain. 71: 285-95. PMID 9231872 DOI: 10.1016/S0304-3959(97)03365-4  0.92
1997 Dickenson AH, Chapman V, Green GM. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. General Pharmacology. 28: 633-8. PMID 9184794 DOI: 10.1016/S0306-3623(96)00359-X  0.92
1997 Chapman V, Dickenson AH. Inflammation reveals inhibition of noxious responses of rat spinal neurones by carbamazepine. Neuroreport. 8: 1399-404. PMID 9172143  0.92
1997 Buritova J, Chapman V, Honoré P, Besson JM. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats. European Journal of Pharmacology. 320: 73-80. PMID 9049605 DOI: 10.1016/S0014-2999(96)00872-2  0.92
1996 Chapman V, Buritova J, Honoré P, Besson JM. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression. Journal of Neurophysiology. 76: 1817-27. PMID 8890294  0.92
1996 Stanfa LC, Chapman V, Kerr N, Dickenson AH. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. British Journal of Pharmacology. 118: 1875-7. PMID 8864517  0.92
1996 Buritova J, Chapman V, Honoré P, Besson JM. Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception. European Journal of Pharmacology. 303: 91-100. PMID 8804916 DOI: 10.1016/0014-2999(96)00074-X  0.92
1996 Buritova J, Chapman V, Honoré P, Besson JM. The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat. Neuroscience. 73: 487-96. PMID 8783264 DOI: 10.1016/0306-4522(96)00071-1  0.92
1996 Honoré P, Chapman V, Buritova J, Besson JM. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study. The Journal of Pharmacology and Experimental Therapeutics. 278: 393-403. PMID 8764375  0.92
1996 Buritova J, Chapman V, Honoré P, Besson JM. Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the rat. Brain Research. 715: 217-20. PMID 8739641 DOI: 10.1016/0006-8993(95)01574-4  0.92
1996 Honoré P, Chapman V, Buritova J, Besson JM. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Anesthesiology. 85: 150-60. PMID 8694361 DOI: 10.1097/00000542-199607000-00021  0.92
1994 Chapman V, Haley JE, Dickenson AH. Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology. 81: 1429-35. PMID 7992912 DOI: 10.1097/00000542-199412000-00018  0.92
1992 Dickenson A, Haley J, Schachter M, Chapman V. Electrophysiological approaches to the study of bradykinin and nitric oxide in inflammatory pain. Agents and Actions. Supplements. 38: 358-65. PMID 1334336  0.92
Show low-probability matches.